Elsevier Announces New Brain Research Editor-In-Chief

New Appointment Aimed at Maintaining the Ethos, Heritage and Uniqueness of This Pioneering Journal in the Field of Neuroscience

OXFORD, England, November 9, 2010 - Elsevier, a world-leading publisher of scientific, technical and medical
information products and solutions, is pleased to announce that Dr. Irwin
B.Levitan has accepted the position of Editor-in-Chief of the journal Brain
Research. He succeeds Dr. Floyd E. Bloom, who has served with distinction as
an Editor of the journal since its inception in 1967 and, latterly since
2000, as its Editor-in-Chief. In his new role, Dr. Levitan will lead this
popular multidisciplinary journal devoted to fundamental research in the
brain sciences.

Dr. Levitan is Founding Chair of the Department of Neuroscience at
Jefferson Medical College of Thomas Jefferson University in Philadelphia and
has played an active part in the field of neuroscience for 35 years. He is
also currently Director of the Farber Institute for Neurosciences at
Jefferson and has received numerous awards and honors, including two
successive NIH Jacob Javits Neuroscience Investigator Awards and two awards
from the McKnight Endowment Fund for Neuroscience. He is a Fellow of the
American Association for the Advancement of Science and has played prominent
leadership roles in the Society for Neuroscience. Earlier this year, he was
appointed President of the Association of Medical School Neuroscience
Department Chairs.

Upon his appointment, Dr. Levitan commented, "I am excited to assume the
role of Editor-in-Chief and I make a commitment to retain the tradition and
unique characteristics of Brain Research to ensure the long term success of
this great journal."

Dr. Levitan has been Senior Editor for Neuroscience for the Encyclopedia
of Life Sciences and a Reviewing Editor for the Journal of Neuroscience. In
addition, he is co-editor of "Ion Channels and Receptors", and a special
issue of Neuropharmacology on "Potassium Channels". He is also co-author of
Neuromodulation: The Biochemical Control of Neuronal Excitability, and
co-author of a widely-used textbook, The Neuron: Cell and Molecular Biology.

About Brain Research

Brain Research (journals.elsevier.com/00068993/brain-research/)
publishes papers reporting interdisciplinary investigations of nervous system
structure, function and chemistry at all levels of resolution, from molecular
to behavioral and social that are of general interest to the broad community
of neuroscientists. Clinical investigations, Protocols (i.e. methods papers)
and Reviews will also be considered for publication if they provide
significant insight into the structure or function of the nervous system, the
pathophysiology of a disease, or its treatment.

The journal has recently launched its new website at
www.elsevier.com/locate/brainres and is sponsoring a satellite event
on "The Emerging Neuroscience of Autism Spectrum Disorders: etiologic
insights; treatment opportunities" prior to the 2010 Society for Neuroscience
meeting in San Diego, 11-12th November 2010
www.brainresearch2010.com/.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (www.thelancet.com/) and
Cell (www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/), Reaxys (www.reaxys.com/), MD Consult
(www.mdconsult.com/) and Nursing Consult (
www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com/), employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC (www.reedelsevier.com/), a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).

    Media Contact
    Felicity Simmonds
    +44-1865-843654
    f.simmonds@elsevier.com

Media Contact: Felicity Simmonds, +44-1865-843654, f.simmonds at elsevier.com